Bhavani S Shankar

4PUBLICATIONS
2CO-AUTHORS
Solid tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 26, 2026
TGF-β-producing tBregs are associated with poor survival rates in PTGS2-high cancers.

|Oct 07, 2024
Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment.

Sharvari Satam, Nitya Palekar, Kavitha Premkumar

|Dec 16, 2020
Proteomic analysis of radio-resistant breast cancer xenografts: Increased TGF-β signaling and metabolism.

Poonam Yadav, Vipul K Pandey, Bhavani S Shankar

|Jul 15, 2020
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B-T cell axis and decreases tumour burden in murine fibrosarcoma.

Kavitha Premkumar, Bhavani S Shankar

Pageof 1

Frequent Collaborators

1 joint publications

Kavitha Premkumar

1 joint publications

Mohit Kumar Jolly